Stock 000908 HUNAN JINGFENG PHARMACEUTICAL CO.,LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Hunan Jingfeng Pharmaceutical Co.,Ltd.

Equities

000908

CNE000000Y11

Pharmaceuticals

End-of-day quote Shenzhen S.E.
Other stock markets
 06:00:00 2024-05-16 pm EDT 		5-day change 1st Jan Change
1.87 CNY +5.06% Intraday chart for Hunan Jingfeng Pharmaceutical Co.,Ltd. +11.98% -42.28%
Apr. 29 Hunan Jingfeng Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 29 Hunan Jingfeng Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Business Summary

Hunan Jingfeng Pharmaceutical Co.,Ltd., formerly Hunan Tianyi Science and Technology Co., Ltd, is a China-based company principally engaged in the research, development, manufacture and sale of chemical drugs, biochemical drugs and traditional Chinese patent drugs. The Company's main products includes cardio and cerebrovascular drugs, antihypertensive and hypolipidemic drugs, orthopedic drugs, anti-tumor products, endocrine drugs, digestive system drugs, antiviral drugs and anti-infective drugs, among others. The Company is also involved in commodity import and export trading, business management and consulting, as well as medical technology consulting business. The Company distributes its products in the domestic market.

Number of employees: 645

Sales per Business

CNY in Million2022Weight2023Weight Delta
Injection
57.3 %
519 61.7 % 377 57.3 % -27.39%
Solid Preparations
28.1 %
201 23.9 % 185 28.1 % -8.22%
Other
14.6 %
118 14.0 % 96 14.6 % -18.89%

Sales per region

CNY in Million2022Weight2023Weight Delta
China
100.0 %
841 100.0 % 657 100.0 % -21.86%

Managers

Managers TitleAgeSince
Xiang Wu Ye FOU
 Founder 72 98-12-08
Yuan Bi BRD
 Director/Board Member 36 18-07-19
Min Chen IRC
 Investor Relations Contact 45 -
Xian Peng Ma PRN
 Corporate Officer/Principal 45 17-12-27

Members of the board

Members of the board TitleAgeSince
Xiang Wu Ye FOU
 Founder 72 98-12-08
Xiong Wen Hu BRD
 Director/Board Member 58 14-12-28
Yuan Bi BRD
 Director/Board Member 36 18-07-19
Shu Qing Xie BRD
 Director/Board Member 56 21-01-25
Xiao Qing Teng CHM
 Chairman 59 21-01-25
Ting Liu BRD
 Director/Board Member 43 23-04-23
Pei Yi Di BRD
 Director/Board Member 39 23-04-23
Shao Xian Zhong BRD
 Director/Board Member 50 21-10-27
Shen Dong Zhou BRD
 Director/Board Member 33 23-04-06

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 879,774,351 732,508,233 ( 83.26 %) 0 83.26 %

Shareholders

NameEquities%Valuation
China Asset Management Co., Ltd.
0.0396 %
280,200 0.0396 % 65 345 ¥
Sealand Securities Co., Ltd. (Investment Management)
0.008302 %
58,700 0.008302 % 13 689 ¥
Essence Fund Co., Ltd.
0.004540 %
32,100 0.004540 % 7 486 ¥
CICC Fund Management Ltd.
0.000933 %
6,600 0.000933 % 1 539 ¥

Company contact information

Hunan Jingfeng Pharmaceutical Co., Ltd.

Room 9-1, 9th Floor, Building C Federation of Industry & Commerce

265701, Yantai

+86 21 6686 1001

http://www.jfyiyao.com
address Hunan Jingfeng Pharmaceutical Co.,Ltd.(000908)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
HUNAN JINGFENG PHARMACEUTICAL CO.,LTD. Stock Hunan Jingfeng Pharmaceutical Co.,Ltd.
-42.28% 217M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+32.09% 694B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+29.39% 593B
JOHNSON & JOHNSON Stock Johnson & Johnson
-1.34% 371B
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.34% 331B
ABBVIE INC. Stock AbbVie Inc.
+7.39% 290B
ASTRAZENECA PLC Stock AstraZeneca PLC
+14.25% 239B
ROCHE HOLDING AG Stock Roche Holding AG
-3.03% 209B
NOVARTIS AG Stock Novartis AG
+10.02% 209B
AMGEN INC. Stock Amgen Inc.
+8.49% 169B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 000908 Stock
  4. Company Hunan Jingfeng Pharmaceutical Co.,Ltd.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW